Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c ‐Fos/NFATc1 signaling pathway

ConclusionsOur study demonstrated that AA suppressed bone metastatic breast cancer. These findings indicate AA as a potential, novel curative drug candidate for patients with bone metastatic breast cancer.

Source: Cancer Medicine - September 24, 2020 Category: Cancer & Oncology Authors: Wenli Jiang, Youlutuziayi Rixiati, Hao Huang, YiJun Shi, Caiguo Huang, Binghua Jiao Tags: ORIGINAL RESEARCH Source Type: research